Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

Botulinum neurotoxin (BoNT) serotypes A, B and E are responsible for most cases of human botulism. The only approved therapy for botulism is antitoxin treatment administered to patients after symptom onset. However, a recent meta-analysis of antitoxin efficacy in human botulism cases over the past c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Dis Model Mech
Main Authors: Torgeman, Amram, Schwartz, Arieh, Diamant, Eran, Baruchi, Tzadok, Dor, Eyal, Ben David, Alon, Pass, Avi, Barnea, Ada, Tal, Arnon, Rosner, Amir, Rosen, Osnat, Zichel, Ran
Format: Artigo
Jezik:Inglês
Izdano: The Company of Biologists Ltd 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177009/
https://ncbi.nlm.nih.gov/pubmed/30115749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1242/dmm.035089
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki